Sun.Jun 16, 2024

article thumbnail

Inside Anthony Fauci’s ‘On Call’: 9 health and science takeaways from the memoir of America’s most famous doctor

STAT

Anthony Fauci spent 40 years in the top echelons of government. It was no accident. To read the forthcoming memoir by the country’s former top infectious disease expert, “On Call: A Doctor’s Journey in Public Service,” a copy of which was obtained by STAT, is to get a sense of his finesse while advising seven presidents. He strove, he writes, to speak with complete candor and stay out of politics, while remaining strategic in pushing for policies he considered vital t

145
145
article thumbnail

Weekend ICYMI: June 10 to June 14

Drug Topics

In case you missed it, this week we had news about e-cigarette task forces, combination COVID-19–flu vaccines, updating education on LGBT pain management, and more.

Vaccines 144
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Ambitious federal study failed to curb opioid deaths, NIH announces

STAT

In 2019, amid an ever-worsening drug crisis, the federal government launched a research study with an ambitious goal: to lower opioid overdoses in participating communities by 40% using evidence-based interventions like distributing naloxone and providing access to addiction medications. But communities that implemented the public health strategies did not see a statistically significant reduction in opioid overdose deaths, according to data published Sunday in the New England Journal of Medicin

143
143
article thumbnail

Growing Use of Herbal Medicine in Cancer Patients Highlights Risks, Communication Gaps

Pharmacy Times

As patients take more proactive roles in their health, they may feel too intimidated to discuss herbal medicinal use with their providers or may be unaware of potential interactions with their drug therapies.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Opinion: I cried tears of loss and rage at the World Hepatitis Summit

STAT

At this year’s World Hepatitis Summit in Lisbon, Portugal, the World Hepatitis Alliance presented me with an award that recognized my leadership as the organization’s president and my advocacy efforts to “improve the lives of people living with viral hepatitis.” As the citation was read aloud, tears started to flow — not tears of joy and pride but of loss and rage.

122
122
article thumbnail

J&J’s nipocalimab raises hope for Sjogren’s patients

pharmaphorum

J&J’s ‘Swiss army knife’ for autoimmune diseases, FcRn inhibitor nipocalimab, has shown efficacy in Sjogren’s disease

119
119

More Trending

article thumbnail

BCGP Exam Study Tips – I Passed! (Again)

Med Ed 101

I recently took the Board Certified Geriatric Pharmacist (BCGP) exam in the spring of 2024 and continue to work in geriatrics. I’m happy to report this was the third time I’ve taken and passed the exam (and recertification exam). I’ve maintained my BCGP certification (formerly CGP) since 2011. I can safely say that I feel […] The post BCGP Exam Study Tips – I Passed!

105
105
article thumbnail

AZ’s Calquence extends disease-free survival in MCL

pharmaphorum

AstraZeneca’s Calquence improved progression-free survival in previously untreated mantle cell lymphoma in the ECHO trial

104
104
article thumbnail

EHA 2024: Roche’s Columvi competes in BiTE battle with positive results in DLBCL

Pharmaceutical Technology

Based on the latest STARGLO trial results, there is potential to extend Columvi into earlier lines of therapy for diffuse large B-cell lymphoma (DLBCL).

52